WASHINGTON -- A report released today has parents and researchers shocked at how far the Institute of Medicine (IOM) and Centers for
Disease Control and Prevention (CDC) will go to protect the reputation of the vaccination
program. After CDC-funded hearings were held in front of an IOM panel on
Feb. 9, 2004 regarding the connection between vaccines and autism, IOM
released its decision today by stating there is no connection, despite strong
clinical evidence from accredited doctors and researchers that suggests
otherwise.
To reach their decision, the National Autism Association says the IOM relied heavily upon CDC's Vaccine Safety
Database (VSD) study published in the Journal of Pediatrics in November 2003.
Many critics have come forward questioning its validity. The study's author,
Dr. Thomas Verstraeten, works for a leading vaccine manufacturer. He also
authored the first CDC VSD study in 2000, obtained through FOIA, which found a
statistically significant link between thimerosal containing vaccines and
autism, but the study was not released to the public.
The National Autism Association (NAA), supporting families and physicians
looking for effective treatments for autism and other neurodevelopmental
disorders, says the report proves the IOM has not been able to divest itself
from vaccine policies. And tragically, in doing so, they have failed society
by their blindness to the issue at hand. "It appears the IOM's admitted fear
of an undermined vaccination program has led to this decision, not scientific
evidence," says Lori McIlwain, executive director of the National Autism
Association.
The NAA states they are for safe vaccines and stand by the clinical evidence
that was presented to the IOM from highly accredited researchers, along with
medical records of affected children. "Thousands of parents have seen the
regression of skills in their children following thimerosal-containing
vaccines," says Jo Pike, president of the National Autism Association. "Many
of these same children are progressing rapidly with biomedical interventions
addressing mercury poisoning. The cause and effect should not be ignored," she
says.
In their report, the IOM panel dismissed strong clinical and
epidemiological evidence presented during the hearings. These studies include:
- Dr. Mark Geier and David Geier presented epidemiological evidence that
children who received thimerosal-containing vaccines were six times
more likely to have autism than children who did not.
- Mady Hornig, MD, showed mice that had been given thimerosal-containing
vaccines and subsequently developed harmful repetitive behaviors
similar to those of autism.
- David Baskin, MD, showed the neurotoxic affects of ethylmercury and how
such damage can lead to apoptosis of cells.
- Jeff Bradstreet, MD, showed that autistic children had six times more
mercury in their bodies than age and vaccine-matched controls.
- Boyd Haley showed that autistic children have less mercury in
their hair than controls hypothesizing that autistic children can not
detoxify as easily as regular children.
"The IOM took over 10 years to acknowledge Gulf War Syndrome and over 20
years to acknowledge Agent Orange poisoning," says Laura Bono, NAA chairman.
"We are asking the IOM to affirm the mass poisoning of thousands of children
through mercury in their vaccines. We are confident that the truth will
eventually come out and we will not be deterred until it does."
Source: National Autism Association
Genomic Surveillance A New Frontier in Health Care Outbreak Detection
November 27th 2024According to new research, genomic surveillance is transforming health care-associated infection detection by identifying outbreaks earlier, enabling faster interventions, improving patient outcomes, and reducing costs.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.